Matches in Wikidata for { <http://www.wikidata.org/entity/Q73048625> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q73048625 description "article scientifique publié en 1997" @default.
- Q73048625 description "artikull shkencor i botuar më 01 shkurt 1997" @default.
- Q73048625 description "artículu científicu espublizáu en febreru de 1997" @default.
- Q73048625 description "im Februar 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73048625 description "scientific article published on 01 February 1997" @default.
- Q73048625 description "wetenschappelijk artikel" @default.
- Q73048625 description "наукова стаття, опублікована в лютому 1997" @default.
- Q73048625 name "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 name "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 name "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 type Item @default.
- Q73048625 label "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 label "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 label "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 prefLabel "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 prefLabel "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 prefLabel "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 P1433 Q73048625-EE06D135-55E9-4F6E-8875-1D55255F40BE @default.
- Q73048625 P1476 Q73048625-01054047-24BA-4BC7-99F8-10D9C64885BF @default.
- Q73048625 P2093 Q73048625-1E3B9429-9BBA-4628-B8FB-958066ACE637 @default.
- Q73048625 P2093 Q73048625-33A82556-5C52-4A8B-8B11-0290718C7D36 @default.
- Q73048625 P2093 Q73048625-511D6415-2C54-4660-92E0-F6DAC13396D1 @default.
- Q73048625 P2093 Q73048625-98508FEC-9A4C-49D7-85FB-DF23CAE85508 @default.
- Q73048625 P2093 Q73048625-C8DC7D6D-A271-4E96-A63B-5032746247EA @default.
- Q73048625 P2860 Q73048625-BB75A320-0DBB-43A5-9721-C4515C8B6EC1 @default.
- Q73048625 P304 Q73048625-1E609D20-C84C-4E19-B5F8-276C40813986 @default.
- Q73048625 P31 Q73048625-19A16AAC-62F4-4757-95E4-F69504B29AE3 @default.
- Q73048625 P356 Q73048625-A297ACA0-302E-4D00-B792-57113E298AEB @default.
- Q73048625 P407 Q73048625-1D9D180C-4A31-4283-916E-5FA278409FBF @default.
- Q73048625 P433 Q73048625-DFEAFD61-4EAE-42F9-B708-7F98945158EF @default.
- Q73048625 P478 Q73048625-C080B974-D6C8-40B2-B5EA-9B667AC0F0EB @default.
- Q73048625 P577 Q73048625-FB3EA4A5-57D8-4A3C-8A89-084BBB4F7EBF @default.
- Q73048625 P698 Q73048625-B9523C95-551A-4E41-BEDF-1FD558A43463 @default.
- Q73048625 P921 Q73048625-1598B8B9-C97A-4A09-A9B0-F628CC1DC2F8 @default.
- Q73048625 P921 Q73048625-497FE827-ACB1-4781-A515-A26FAC6D7711 @default.
- Q73048625 P921 Q73048625-93D60AAA-14E6-4578-B528-EBAC134A3289 @default.
- Q73048625 P921 Q73048625-C14766CA-053B-4F8B-B382-0CCDADACCF13 @default.
- Q73048625 P921 Q73048625-C4FE5FDE-8E4F-42BE-97FE-9CF9EF56074D @default.
- Q73048625 P356 (SICI)1097-0142(19970215)79:4%3C740::AID-CNCR11%3E3.0.CO;2-%23 @default.
- Q73048625 P698 9024712 @default.
- Q73048625 P1433 Q326041 @default.
- Q73048625 P1476 "Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial" @default.
- Q73048625 P2093 "Birch R" @default.
- Q73048625 P2093 "Greco FA" @default.
- Q73048625 P2093 "Hainsworth JD" @default.
- Q73048625 P2093 "Hopkins LG" @default.
- Q73048625 P2093 "Jolivet J" @default.
- Q73048625 P2860 Q34298656 @default.
- Q73048625 P304 "740-748" @default.
- Q73048625 P31 Q13442814 @default.
- Q73048625 P356 "10.1002/(SICI)1097-0142(19970215)79:4<740::AID-CNCR11>3.0.CO;2-#" @default.
- Q73048625 P407 Q1860 @default.
- Q73048625 P433 "4" @default.
- Q73048625 P478 "79" @default.
- Q73048625 P577 "1997-02-01T00:00:00Z" @default.
- Q73048625 P698 "9024712" @default.
- Q73048625 P921 Q18555947 @default.
- Q73048625 P921 Q238512 @default.
- Q73048625 P921 Q422232 @default.
- Q73048625 P921 Q42824440 @default.
- Q73048625 P921 Q974135 @default.